Skip to main content
Figure 2 | Virology Journal

Figure 2

From: An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

Figure 2

Cross-reactivity of H5N1-M2e-MAP-induced antibody against H1N1-M2e peptide. Mice were primed and boosted with H5N1-M2e-MAP vaccine and sera were collected as described in Materials and Methods to detect cross-reactivity against H1N1-M2e by ELISA. The end-point titer of each sample was determined as the highest dilution that yielded an OD450 nm value greater than twice of that from pre-vaccination. The data are expressed as mean ± standard deviation (SD) of 10 mice per group. The lower limit of detection (1:20) is indicated by a dotted line. Time points of immunizations are shown as small spots on X-axis, and indicated by arrows at the bottom.

Back to article page